+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 21Years - 80Years
All Genders
ID07282041

Study of Dulaglutide Injection with Standard Therapy to Improve Brain Blood Flow in Adults with Severe Narrowing of Brain Arteries and Recent Stroke or TIA

Led by National University of Singapore · Updated on 2025-12-23

130

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the effect of glucagon-like peptide 1 receptor agonist GLP1 RA therapy, specifically Dulaglutide, on patients with severe and recently symptomatic narrowing stenosis of the intracranial carotid artery ICA or middle cerebral artery MCA. The study focuses on improving cerebral vasodilatory reserve CVR, an important measure of blood vessel function in the brain, in patients with intracranial atherosclerotic disease ICAD. Researchers hypothesize that GLP1 RA may benefit these patients by improving blood flow and reducing stroke risk. Participants will be randomly assigned to receive either the best medical therapy alone or in combination with Dulaglutide given as a weekly subcutaneous injection starting at 0.75 mg and possibly increasing to 1.5 mg. The study is open-label and lasts for two years, with CVR measured at baseline and after one year using transcranial Doppler breath holding index and acetazolamide-challenged single photon emission computed tomography SPECT. Brain MRI scans will also be performed to check for new ischemic lesions. Throughout the study, participants will be monitored for cerebral ischemic events for two years. Researchers will assess changes in CVR and the occurrence of strokes, transient ischemic attacks TIA, myocardial infarctions, and major adverse cardiovascular events MACE. Safety will be tracked by recording any side effects related to Dulaglutide. The trial aims to provide important information about the potential benefits of GLP1 RA therapy in managing severe ICAD.

CONDITIONS

Brief Title

Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis

Research Team

V

vijay K sharma, MD

L

Lily YH Wong, RN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here